All 5/6 nephrectomized animals demonstrated significant reduction in kidney function, hypertension, proteinuria and elevated serum FGF23 levels, with no significant differences between vehicle- and anti-FGFR4-treated animals, as summarized in Table 1. The gene discussed is FGFR4; the disease is Hypertension.